Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Osmotic gradients in the airway mucus and extracellular fluid represent a critical physiological target for the treatment of muco-obstructive lung diseases. These gradients are primarily regulated by the active transport of ions across the airway epithelium, which dictates the movement of water into or out of the airway surface liquid (ASL) (Boucher, R. C., 2007, Journal of Internal Medicine). In a healthy respiratory system, the balance of ion transport—primarily through the cystic fibrosis transmembrane conductance regulator (CFTR) and the epithelial sodium channel (ENaC)—maintains an osmotic environment that ensures mucus remains hydrated and easily cleared by ciliary action. In diseases such as cystic fibrosis, the loss of chloride secretion and excessive sodium absorption lead to a dehydrated ASL and hyper-concentrated mucus, which impairs mucociliary clearance and facilitates chronic infection (Elkins, M. R., et al., 2006, NEJM). Therapeutic intervention involves the administration of inhaled osmotic agents like hypertonic saline or mannitol. These agents increase the osmotic pressure within the airway lumen, drawing water from the submucosal space to rehydrate the mucus, thereby improving its rheological properties and facilitating mechanical clearance via coughing or ciliary movement (Daviskas, E., et al., 2010, Chest).
Osmotic agents increase the solute concentration in the airway surface liquid (ASL), creating an osmotic pressure gradient that draws water from the epithelial cells and interstitial space into the mucus layer to improve hydration and rheology (Boucher, 2007; Elkins et al., 2006).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Osmotic gradients in airway mucus and extracellular fluid.